Boston Scientific posts better-than-expected Q3 earnings

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.

Boston Scientific Corp. BSX, -1.90% posted better-than-expected third-quarter earnings early Thursday and raised its full-year guidance. The medical technology company had net income of $505 million, or 34 cents a share, for the quarter, up from $174 million, or 12 cents a share, in the year-earlier period.

Adjusted per-share earnings came to 50 cents, ahead of the 48 cent FactSet consensus. Sales rose to $3.527 billion from $3.170 billion a year ago, also ahead of the $3.477 billion FactSet consensus. The company now expects full-year adjusted EPS of $1.99 to $2.02, while FactSet is expecting $2.00. It expects full-year sales to rise 11%. The stock has gained 8% in the year to date, while the S&P 500 SPX, -1.43% has gained 9%.

 

コメントありがとうございます。コメントは審査後に公開されます。
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 3. in JP

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Penske Automotive’s stock slides premarket after profit miss amid ‘challenging’ used car marketCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
ソース: MarketWatch - 🏆 3. / 97 続きを読む »